Assembly Biosciences Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

SOUTH SAN FRANCISCO, Calif., Nov. 10, 2023 -- Assembly Biosciences, Inc. , a biotechnology company developing innovative antiviral therapeutics targeting serious viral diseases, today announced a...

Related Keywords

Anuj Gaggar ,Shannon Ryan ,Assembly Bio ,Nasdaq ,Corporate Affairs ,Alliance Management ,Assembly Biosciences Inc ,Assembly Biosciences ,Chief Medical ,Award Plan ,Incentive Plan ,Compensation Committee ,Nasdaq Listing Rule ,Investor Relations ,Markets ,